Science Sparks @ ACTREC
![Date Image Date Image](https://actrec.gov.in/themes/actrec/images/SSA/Images/date-email.png)
Publications
- 1. Ketkar M, Desai S, Rana P, Thorat R, Epari S, Dutt A, Dutt S (2024). Inhibition of PERK mediated UPR acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma. Neuro Oncology.
- 2. Ramaswamy A, Chaudhari V, Srinivas S, Bhargava P, Kannan S, Agarwal A, Seshadri RA, Talwar V, Goel S, Goel V, Singh S, Kayal S, Rebala P, Rao GV, Prajapati B, Parikh D, Kothari J, Kadamapuzha JM, Ramesh H, Kapoor D, Chaudhary A, Gupta A, Sekar A, Misra S, Vishnoi JR, Soni S, Varshney VK, Bairwa SK, Ghosh J, Lavingia V, Bhandare M, Shrikhande SV, Ostwal V (2024). Adjuvant therapy may improve overall survival in high-risk periampullary adenocarcinomas patients - A match-pair analysis from a multi-institutional cohort study (The MIPPAP study). HPB (Oxford).
- 3. Singh A, Patil J, Ghogale SG, Deshpande N, Girase K, Shetye N, Rajpal S, Chatterjee G, Patkar N, Jain D, Epari S, Shet T, Gujral S, Subramanian PG, Tembhare PR (2024). Utility of leukocyte-associated immunoglobulin-like receptor-1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B-cell non-Hodgkin lymphoma. Cytometry B Clinical Cytometry.
- 4. Nguyen NP, Karlsson UL, Page BR, Chirila ME, Vinh-Hung V, Gorobets O, Arenas M, Mohammadianpanah M, Javadinia SA, Giap H, Kim L, Dutheil F, Murthy V, Mallum AA, Tlili G, Dahbi Z, Loganadane G, Blanco SC, Bose S, Natoli E, Li E, Morganti AG (2024). Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group. Frontiers in Oncology. 14:1371752
- Thesis
Swapnil Sudhir Oak. 2024. Exploring Mutant p53-associated Functions and Pathways that Promote Tumorigenesis. (LIFE09201604002) (Guide: Dr. Tanuja Teni).
![desktop Image desktop Image](https://actrec.gov.in/themes/actrec/images/SSA-Images/REACTOME.png)
Upcoming Events
31st August, 2024
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
24- 28th September 2024
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
Pre Conference Workshop November 28, 2024 Conference 29-30th November 2024
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai & CIDCO Convention Centre, Vashi, Navi Mumbai
Do You Know?
In In 1975, Georges Kohler and Cesar Milstein developed the technique (hybridoma technology) for producing monoclonal antibodies against defined proteins.
![back Image back Image](https://actrec.gov.in/themes/actrec/images/SSA/Images/dyk-back.png)
Cancer News
Neuroscience News, 17/07/2024
Researchers developed a new method, burst sine wave electroporation (B-SWE), to treat glioblastoma, a fast-growing brain tumor. B-SWE disrupts the blood-brain barrier more effectively than traditional methods, allowing cancer drugs better access to the brain...
MedicalXpress, 18/07/2024
In the study, 130 relapsed follicular lymphoma patients from 31 medical centers in North America, Europe and Japan received lisocabtagene maraleucel (liso-cel), a type of CAR T-cell therapy, over the course of two years...
EurekAlert, 17/07/2024
The team identified a distinct TNF-α (tumor necrosis factor alpha) program, a signaling pathway that plays a crucial role in inflammation and cellular communication. During clonal expansion in normal epithelia, TNF-α signaling is provided by the surrounding environment involving immune cells...
© 2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)